XML 69 R58.htm IDEA: XBRL DOCUMENT v3.25.3
DEBT AND CREDIT FACILITIES (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Mar. 19, 2025
Sep. 04, 2024
Apr. 17, 2024
Sep. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 30, 2025
Dec. 31, 2024
Short-Term Debt [Line Items]                    
Interest paid-in-kind             $ 1,593,416 $ 424,067    
Interest expense related to back-end fee       $ 1,818,105   $ 927,577 4,926,765 1,839,259    
Minimum cash balance       3,000,000.0     3,000,000.0      
Annual minimum revenue, year ending December 31, 2024             60,000,000.0      
Annual minimum revenue, year ending December 31, 2025             75,000,000.0      
Annual minimum revenue, year ending December 31, 2026             85,000,000.0      
Annual minimum revenue, year ending December 31, 2027             95,000,000.0      
Annual minimum revenue, January 1, 2028 thereafter             105,000,000.0      
Amortization of Debt Issuance Costs             206,363 150,219    
CRG Term Loan [Member]                    
Short-Term Debt [Line Items]                    
Debt Issuance Costs, Gross       228,183     $ 228,183     $ 1,160,740
CRG Term Loan Agreement [Member]                    
Short-Term Debt [Line Items]                    
Secured term loan     $ 55,000,000.0              
Loans borrowed   $ 15,500,000 15,000,000.0              
Remaining amount available for borrowing     $ 40,000,000.0              
Debt description (i) entitle the Company to two additional borrowings following the Second Borrowing, which borrowings must occur on or prior to December 31, 2025, if at all, and (ii) remove the requirement that any borrowing be in whole multiples of $5.0 million. The total available borrowing amount under the facility and the related interest rate and fees were not modified. Any additional borrowings under the CRG Term Loan will be subject to the satisfaction of certain conditions, including the Agent having received certain fees           each such borrowing was at least $5.0 million and occurred between the Closing Date and June 30, 2025      
Proceeds from loans used for investment   $ 5,000,000.0                
Loans borrowed         $ 12,250,000          
Interest rate per annum     13.25%              
Incremental increase during an event of default     4.00%              
Cash paid percentage     8.00%              
Paid-in-kind and aggregate principal loan amount, percentage     5.25%              
Debt upfront fee percentage     1.50%              
Debt instrument back-end fee percentage     7.00%              
Interest paid       911,499   399,532 $ 2,428,062 646,199    
Interest paid-in-kind       598,172   262,193 1,593,416 424,067    
Debt instrument rate description     (i) if prepayment occurs on or prior to the date that is one year following the applicable borrowing (the “Borrowing Date”), an amount equal to 10.0% of the aggregate outstanding principal amount of the CRG Term Loan being prepaid and (ii) if prepayment occurs one year after the applicable Borrowing Date and on or prior to two years following the applicable Borrowing Date, an amount equal to 5.0% of the aggregate outstanding principal amount of the CRG Term Loan being prepaid              
CRG Term Loan Agreement [Member] | Backend Fee [Member]                    
Short-Term Debt [Line Items]                    
Interest expense related to back-end fee       $ 201,411   $ 167,189 $ 578,901 $ 219,689    
CRG Term Loan Agreement [Member] | Forecast [Member]                    
Short-Term Debt [Line Items]                    
Available amount for borrowing                 $ 12,250,000  
First Borrowing [Member]                    
Short-Term Debt [Line Items]                    
Debt instrument maturity date         Mar. 30, 2029          
Second Borrowing [Member]                    
Short-Term Debt [Line Items]                    
Debt instrument maturity date         Mar. 30, 2029          
Third Borrowing [Member]                    
Short-Term Debt [Line Items]                    
Debt instrument maturity date         Mar. 30, 2029